UBS Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$63.8M Sell
476,138
-265,197
-36% -$35.5M 0.01% 1032
2025
Q1
$49.9M Buy
741,335
+151,093
+26% +$10.2M 0.01% 1167
2024
Q4
$36.8M Buy
590,242
+530,990
+896% +$33.1M 0.01% 1311
2024
Q3
$9.3M Buy
59,252
+26,841
+83% +$4.21M ﹤0.01% 1736
2024
Q2
$4.88M Sell
32,411
-12,788
-28% -$1.93M ﹤0.01% 2156
2024
Q1
$3.34M Buy
45,199
+4,936
+12% +$365K ﹤0.01% 2541
2023
Q4
$3.18M Buy
40,263
+16,309
+68% +$1.29M ﹤0.01% 2421
2023
Q3
$1.31M Buy
23,954
+20,904
+685% +$1.14M ﹤0.01% 2889
2023
Q2
$256K Sell
3,050
-11,286
-79% -$948K ﹤0.01% 4292
2023
Q1
$1.09M Buy
14,336
+4,472
+45% +$339K ﹤0.01% 3117
2022
Q4
$609K Buy
9,864
+6,786
+220% +$419K ﹤0.01% 3543
2022
Q3
$128K Sell
3,078
-576
-16% -$24K ﹤0.01% 4455
2022
Q2
$115K Sell
3,654
-9,989
-73% -$314K ﹤0.01% 4327
2022
Q1
$367K Sell
13,643
-11,692
-46% -$315K ﹤0.01% 3964
2021
Q4
$486K Buy
25,335
+22,310
+738% +$428K ﹤0.01% 4009
2021
Q3
$100K Buy
3,025
+675
+29% +$22.3K ﹤0.01% 4756
2021
Q2
$78K Sell
2,350
-1,199
-34% -$39.8K ﹤0.01% 5024
2021
Q1
$148K Sell
3,549
-5,729
-62% -$239K ﹤0.01% 4697
2020
Q4
$184K Buy
9,278
+1,548
+20% +$30.7K ﹤0.01% 4323
2020
Q3
$106K Sell
7,730
-5,888
-43% -$80.7K ﹤0.01% 4319
2020
Q2
$244K Sell
13,618
-896
-6% -$16.1K ﹤0.01% 3873
2020
Q1
$175K Sell
14,514
-8,330
-36% -$100K ﹤0.01% 3989
2019
Q4
$434K Buy
22,844
+11,348
+99% +$216K ﹤0.01% 4005
2019
Q3
$273K Buy
11,496
+4,700
+69% +$112K ﹤0.01% 4143
2019
Q2
$197K Buy
+6,796
New +$197K ﹤0.01% 4116